Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Musculoskelet Neuronal Interact ; 20(2): 291-296, 2020 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-32481245

RESUMO

Vitamin D (vitD) deficiency and bone loss may occur after bariatric surgery and hence, supplementation with high oral doses of vitD may be required. Alternatively, intramuscular depot ergocalciferol, which slowly releases vitD and bypasses the gastrointestinal tract, could be administrated. We present a case of severe vitD deficiency-osteomalacia after gastric bypass operation for morbid obesity, treated with ergocalciferol intramuscularly. A 45-year-old woman was presented with hip pain and muscle weakness, which led ultimately to immobilization in a wheelchair. Fifteen years ago, she underwent roux-en-Y gastric by-pass for morbid obesity. Occasionally, she was treated with multivitamin supplements. On admission, iron deficiency anaemia, vitD deficiency (25OHD: 3.7 ng/ml) and secondary hyperparathyroidism were revealed. Bone turnover markers (BTM) were elevated. Radiological evaluation demonstrated insufficiency fractures on the pubic and left femur and reduced BMD. Osteomalacia due to vitD deficiency and calcium malabsorption were diagnosed. Calcium citrate 500 mg qid and intramuscular ergocalciferol 600,000 IU every 20 days were initiated. One month later, musculoskeletal pain and weakness were resolved and the patient was mobilized. Few months later, vitD, BTM and BMD showed substantial improvement. Intramuscular ergocalciferol administration can improve the clinical and biochemical status and thus, is suggested to prevent and/or treat osteomalacia in such patients.


Assuntos
Conservadores da Densidade Óssea/administração & dosagem , Ergocalciferóis/administração & dosagem , Fraturas de Estresse/etiologia , Derivação Gástrica/efeitos adversos , Osteomalacia/tratamento farmacológico , Deficiência de Vitamina D/tratamento farmacológico , Preparações de Ação Retardada/administração & dosagem , Feminino , Humanos , Injeções Intramusculares , Pessoa de Meia-Idade , Obesidade Mórbida/cirurgia , Osteomalacia/etiologia , Deficiência de Vitamina D/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA